Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Nasdaq Real Time Price USD

Phreesia, Inc. (PHR)

Compare
25.46
-0.10
(-0.39%)
As of 3:58:53 PM EDT. Market Open.
Loading Chart for PHR
  • Previous Close 25.56
  • Open 25.47
  • Bid 25.39 x 900
  • Ask 25.41 x 1000
  • Day's Range 24.94 - 26.06
  • 52 Week Range 17.07 - 30.53
  • Volume 279,831
  • Avg. Volume 460,318
  • Market Cap (intraday) 1.496B
  • Beta (5Y Monthly) 1.03
  • PE Ratio (TTM) --
  • EPS (TTM) -1.02
  • Earnings Date May 28, 2025 - Jun 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 32.31

Phreesia, Inc. engages in the provision of an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers an appointment scheduling system for online appointments, reminders, and referral tracking and management; registration solutions to automate patient self-registration; revenue cycle solutions that provide insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. It deploys its platform in a range of modalities, including Phreesia Mobile, a patients' mobile device; PhreesiaPads, a self-service intake tablets; Phreesia Dashboard, a web-based dashboard for healthcare services clients; and Arrivals Kiosks, which are on-site kiosks. The company serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.

www.phreesia.com

2,082

Full Time Employees

January 31

Fiscal Year Ends

Recent News: PHR

View More

Performance Overview: PHR

Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PHR
1.19%
S&P 500 (^GSPC)
4.28%

1-Year Return

PHR
10.31%
S&P 500 (^GSPC)
7.36%

3-Year Return

PHR
15.19%
S&P 500 (^GSPC)
23.84%

5-Year Return

PHR
31.51%
S&P 500 (^GSPC)
127.87%

Compare To: PHR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PHR

View More

Valuation Measures

Annual
As of 3/31/2025
  • Market Cap

    1.50B

  • Enterprise Value

    1.44B

  • Trailing P/E

    --

  • Forward P/E

    90.91

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.51

  • Price/Book (mrq)

    5.67

  • Enterprise Value/Revenue

    3.42

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -13.94%

  • Return on Assets (ttm)

    -8.75%

  • Return on Equity (ttm)

    -22.67%

  • Revenue (ttm)

    419.81M

  • Net Income Avi to Common (ttm)

    -58.53M

  • Diluted EPS (ttm)

    -1.02

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    439.85M

  • Total Debt/Equity (mrq)

    2.60%

  • Levered Free Cash Flow (ttm)

    28.64M

Research Analysis: PHR

View More

Company Insights: PHR

Research Reports: PHR

View More

People Also Watch